Abbott Laboratories buy JPMorgan Chase & Co.
Start price
20.04.23
/
50%
€101.24
Target price
20.04.24
€111.01
Performance (%)
-0.75%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. During the runtime of the prediction for Abbott Laboratories the price only changed by -0.75%. JPMorgan_Chase___Co_ has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Dividends of €1.96 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Abbott Laboratories | 3.826% | 3.826% | -12.250% | 4.730% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % | 64,25 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % | 84,97 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % | 79,25 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % | 68,08 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at JPMorgan Chase & Co. from $118.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€80.40
17.04.26
17.04.26
€93.41
17.04.27
17.04.27
24.20%
21.08.26
21.08.26
Stopped prediction by JPMorgan_Chase___Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€87.74
17.07.26
17.07.26
€104.90
17.07.27
17.07.27
13.81%
21.08.26
21.08.26